{"id":793997,"date":"2026-04-01T21:30:17","date_gmt":"2026-04-01T19:30:17","guid":{"rendered":"https:\/\/www.hashtag.al\/?p=793997"},"modified":"2026-04-01T21:30:17","modified_gmt":"2026-04-01T19:30:17","slug":"pfizer-e-biontech-ndalojne-studimin-e-vaksines-covid-ne-shba","status":"publish","type":"post","link":"https:\/\/www.hashtag.al\/index.php\/2026\/04\/01\/pfizer-e-biontech-ndalojne-studimin-e-vaksines-covid-ne-shba\/","title":{"rendered":"Pfizer e BioNTech ndalojn\u00eb studimin e vaksin\u00ebs COVID n\u00eb SHBA","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
\"\"

Majtas kreu i Pfizer Albert Bourla, djathtas kreu i BionTech Ugur Sahin<\/span><\/em><\/p><\/div>\n

Pfizer dhe BioNTech ndaluan nj\u00eb studim t\u00eb madh n\u00eb Shtetet e Bashkuara p\u00ebr vaksin\u00ebn e p\u00ebrdit\u00ebsuar kund\u00ebr COVID-19 tek t\u00eb rritur t\u00eb sh\u00ebndetsh\u00ebm t\u00eb mosh\u00ebs 50 deri 64 vje\u00e7, duke deklaruar se regjistrimi i pjes\u00ebmarr\u00ebsve ishte shum\u00eb i ul\u00ebt p\u00ebr t\u00eb prodhuar t\u00eb dh\u00ebnat e nevojshme.<\/span><\/p>\n

N\u00eb nj\u00eb let\u00ebr drejtuar hetuesve t\u00eb studimit, t\u00eb dat\u00ebs 30 mars dhe t\u00eb par\u00eb nga Reuters, Pfizer tha se do t\u00eb ndalonte monitorimin p\u00ebr shenja t\u00eb s\u00ebmundjes COVID p\u00ebr t\u00eb gjith\u00eb pjes\u00ebmarr\u00ebsit pas 3 prillit.<\/span><\/p>\n

Regjistrimi u mbyll m\u00eb 6 mars, pas nj\u00eb rishikimi t\u00eb tendencave aktuale epidemiologjike, thuhej n\u00eb let\u00ebr.<\/span><\/p>\n

Ky vendim vjen n\u00eb nj\u00eb koh\u00eb kur prodhuesit e vaksinave kund\u00ebr COVID po p\u00ebrballen me rezistenc\u00eb nga administrata amerikane dhe me k\u00ebrkes\u00eb t\u00eb dob\u00ebt p\u00ebr vaksinat n\u00eb SHBA.<\/span><\/p>\n

FDA vitin e kaluar ashp\u00ebrsoi k\u00ebrkesat p\u00ebr p\u00ebrdorimin e vaksinave kund\u00ebr COVID, duke k\u00ebrkuar prova t\u00eb m\u00ebdha klinike me placebo p\u00ebr grupmosh\u00ebn 50\u201364 vje\u00e7, n\u00eb m\u00ebnyr\u00eb q\u00eb vaksina t\u00eb p\u00ebrfshihej n\u00eb rekomandime.<\/span><\/p>\n

Pfizer dhe BioNTech i than\u00eb Reuters se kishin informuar FDA-n\u00eb p\u00ebr q\u00ebllimin e tyre p\u00ebr t\u00eb ndalur studimin, duke p\u00ebrmendur v\u00ebshtir\u00ebsit\u00eb p\u00ebr t\u00eb gjetur mjaft pjes\u00ebmarr\u00ebs. Synimi ishte t\u00eb p\u00ebrfshiheshin rreth 25,000 deri 30,000 persona.<\/span><\/p>\n

\u201cKy studim nuk po p\u00ebrfundon p\u00ebr shkak t\u00eb ndonj\u00eb shqet\u00ebsimi mbi sigurin\u00eb apo balanc\u00ebn p\u00ebrfitim-rrezik. Synojm\u00eb ta ndalim p\u00ebr shkak t\u00eb ritmit t\u00eb ngadalt\u00eb t\u00eb regjistrimit dhe pamund\u00ebsis\u00eb p\u00ebr t\u00eb prodhuar t\u00eb dh\u00ebna t\u00eb r\u00ebnd\u00ebsishme pas hedhjes n\u00eb treg,\u201d than\u00eb kompanit\u00eb.<\/span><\/p>\n

Aksionet e Pfizer dhe rivalit Moderna u rrit\u00ebn me rreth 1%, nd\u00ebrsa aksionet e BioNTech t\u00eb listuara n\u00eb SHBA u rrit\u00ebn rreth 2%.<\/span><\/p>\n

Shefi i vaksinave n\u00eb FDA, Vinay Prasad, i cili kishte k\u00ebrkuar prova t\u00eb kontrolluara me placebo p\u00ebr t\u00eb rritur t\u00eb sh\u00ebndetsh\u00ebm dhe f\u00ebmij\u00eb, do t\u00eb largohet nga agjencia k\u00ebt\u00eb muaj. Ekspert\u00ebt paralajm\u00ebruan se k\u00ebrkesa p\u00ebr studime t\u00eb reja t\u00eb m\u00ebdha mund t\u00eb vonoj\u00eb ose kufizoj\u00eb disponueshm\u00ebrin\u00eb e vaksinave t\u00eb p\u00ebrdit\u00ebsuara p\u00ebr grupet me rrezik m\u00eb t\u00eb ul\u00ebt.<\/span><\/p>\n

Nuk \u00ebsht\u00eb e qart\u00eb se cila do t\u00eb jet\u00eb rruga drejt miratimit p\u00ebr k\u00ebt\u00eb grupmosh\u00eb. FDA nuk ishte menj\u00ebher\u00eb e disponueshme p\u00ebr koment. Kompanit\u00eb nuk komentuan mbi planet p\u00ebr tregtimin e vaksin\u00ebs p\u00ebr k\u00ebt\u00eb kategori.<\/span><\/p>\n

Nd\u00ebrprerja e studimit nga Pfizer dhe BioNTech vjen p\u00ebrpara nj\u00eb takimi t\u00eb pritur n\u00eb maj t\u00eb komitetit k\u00ebshillimor t\u00eb FDA-s\u00eb p\u00ebr vaksinat, i cili p\u00ebrdor t\u00eb dh\u00ebnat e studimeve p\u00ebr t\u00eb orientuar vendimet mbi p\u00ebrzgjedhjen e varianteve t\u00eb virusit p\u00ebr vaksinat e vjesht\u00ebs.<\/span><\/p>\n

\u201cPa k\u00ebto t\u00eb dh\u00ebna, ndoshta nuk do t\u00eb ket\u00eb prezantim,\u201d tha Dr. Jesse Goodman, ish-shkenc\u00ebtar kryesor i FDA-s\u00eb. \u201cDhe pa prezantim, mund t\u00eb mos ket\u00eb nj\u00eb miratim specifik p\u00ebr k\u00ebt\u00eb grupmosh\u00eb.\u201d<\/span><\/p>\n

\"\"<\/p>\n

Nj\u00eb grup i v\u00ebshtir\u00eb p\u00ebr t\u2019u rekrutuar<\/strong><\/span><\/p>\n

Dy burime nga kompani q\u00eb menaxhojn\u00eb 18 nga 208 vendet e studimit than\u00eb se Pfizer u kishte k\u00ebrkuar me shkrim n\u00eb fillim t\u00eb marsit t\u00eb ndalonin rekrutimin.<\/span><\/p>\n

Studimi synonte t\u00eb testonte efektivitetin, reagimin imunitar dhe sigurin\u00eb e vaksin\u00ebs s\u00eb p\u00ebrdit\u00ebsuar kund\u00ebr COVID nga Pfizer dhe BioNTech tek t\u00eb rritur t\u00eb sh\u00ebndetsh\u00ebm 50\u201364 vje\u00e7. FDA k\u00ebrkonte q\u00eb pjes\u00ebmarr\u00ebsit t\u00eb mos kishin s\u00ebmundje kronike si hipertension apo diabet.<\/span><\/p>\n

\u201cKy \u00ebsht\u00eb nj\u00eb grup shum\u00eb i v\u00ebshtir\u00eb p\u00ebr t\u2019u rekrutuar,\u201d tha nj\u00eb drejtues n\u00eb nj\u00eb organizat\u00eb k\u00ebrkimore me kontrat\u00eb q\u00eb ishte p\u00ebrfshir\u00eb n\u00eb studim, duke folur n\u00eb kushte anonimiteti.<\/span><\/p>\n

\u201cEdhe kur pacient\u00ebt jan\u00eb t\u00eb gatsh\u00ebm t\u00eb marrin pjes\u00eb n\u00eb studime p\u00ebr COVID, m\u00eb shum\u00eb se 80% nuk kalojn\u00eb faz\u00ebn paraprake sepse nuk plot\u00ebsojn\u00eb kriteret sh\u00ebndet\u00ebsore. Ka qen\u00eb shum\u00eb e v\u00ebshtir\u00eb t\u00eb regjistrohen mjaft pacient\u00eb, ve\u00e7an\u00ebrisht duke pasur parasysh p\u00ebrmas\u00ebn e studimit,\u201d tha ai.<\/span><\/p>\n

Studimi i Moderna vazhdon; k\u00ebrkesa p\u00ebr vaksina bie<\/strong><\/span><\/p>\n

Aktualisht, asnj\u00eb vaksin\u00eb kund\u00ebr COVID nuk ka miratim t\u00eb plot\u00eb nga FDA p\u00ebr t\u00eb rritur t\u00eb sh\u00ebndetsh\u00ebm 50\u201364 vje\u00e7. Vaksinat Comirnaty dhe Spikevax, si dhe vaksina e gjenerat\u00ebs s\u00eb re mNEXSPIKE, jan\u00eb t\u00eb miratuara p\u00ebr t\u00eb rritur mbi 65 vje\u00e7 dhe p\u00ebr persona m\u00eb t\u00eb rinj me rrezik t\u00eb lart\u00eb p\u00ebr forma t\u00eb r\u00ebnda t\u00eb s\u00ebmundjes.<\/span><\/p>\n

Moderna po zhvillon nj\u00eb studim t\u00eb ngjash\u00ebm n\u00eb SHBA me synim regjistrimin e 30,000 vullnetar\u00ebve, por edhe ai po p\u00ebrballet me v\u00ebshtir\u00ebsi n\u00eb rekrutimin e pjes\u00ebmarr\u00ebsve, sipas burimeve nga kat\u00ebr qendra studimi. Studimi pritet t\u00eb p\u00ebrfundoj\u00eb n\u00eb qershor 2027. Moderna nuk iu p\u00ebrgjigj menj\u00ebher\u00eb k\u00ebrkes\u00ebs p\u00ebr koment.<\/span><\/p>\n

Vaksinat kund\u00ebr COVID mbeten produkte t\u00eb r\u00ebnd\u00ebsishme p\u00ebr prodhuesit, megjith\u00ebse k\u00ebrkesa ka r\u00ebn\u00eb ndjesh\u00ebm q\u00eb nga kulmi i pandemis\u00eb.<\/span><\/p>\n

Vet\u00ebm rreth 18% e amerikan\u00ebve mor\u00ebn nj\u00eb doz\u00eb p\u00ebrforcuese gjat\u00eb sezonit 2025\u201326, sipas t\u00eb dh\u00ebnave nga CDC, edhe pse virusi vazhdon t\u00eb shkaktoj\u00eb dhjet\u00ebra mij\u00ebra vdekje \u00e7do vit, p\u00ebrfshir\u00eb rreth 8,000 deri 12,000 vdekje tek t\u00eb rriturit 50\u201364 vje\u00e7.<\/span><\/p>\n

Vaksinat e p\u00ebrdit\u00ebsuara kund\u00ebr COVID p\u00ebr grupet e miratuara zakonisht autorizohen bazuar n\u00eb t\u00eb dh\u00ebna mbi reagimin imunitar, q\u00eb tregojn\u00eb se sa mir\u00eb formula e re prodhon antitrupa kund\u00ebr varianteve n\u00eb qarkullim, nj\u00eb qasje e ngjashme me at\u00eb q\u00eb p\u00ebrdoret p\u00ebr vaksinat sezonale t\u00eb gripit, shkruan Reuters<\/a>.<\/span><\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"

Pfizer dhe BioNTech ndaluan nj\u00eb studim t\u00eb madh n\u00eb Shtetet e Bashkuara p\u00ebr vaksin\u00ebn e p\u00ebrdit\u00ebsuar kund\u00ebr COVID-19 tek t\u00eb rritur t\u00eb sh\u00ebndetsh\u00ebm t\u00eb mosh\u00ebs 50 deri 64 vje\u00e7, duke deklaruar se regjistrimi i pjes\u00ebmarr\u00ebsve ishte shum\u00eb i ul\u00ebt p\u00ebr t\u00eb prodhuar t\u00eb dh\u00ebnat e nevojshme. N\u00eb nj\u00eb let\u00ebr drejtuar hetuesve t\u00eb studimit, t\u00eb dat\u00ebs […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":51,"featured_media":793998,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53],"tags":[],"class_list":["post-793997","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fast-foodi"],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/793997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/users\/51"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/comments?post=793997"}],"version-history":[{"count":99999,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/793997\/revisions"}],"predecessor-version":[{"id":794000,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/posts\/793997\/revisions\/794000"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/media\/793998"}],"wp:attachment":[{"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/media?parent=793997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/categories?post=793997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hashtag.al\/index.php\/wp-json\/wp\/v2\/tags?post=793997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}